Abstract
Introduction
Invasive aspergillosis (IA) is a common opportunistic fungal infection in immunocompromised patients. Early and reliable diagnosis is pivotal in order to improve therapeutic outcomes. 1, 2 It has become clear that T-cell immunity significantly contributes to the defence against mould infections. Recently, it was shown that the quantification of fungusspecific CD154 + T cells may provide a novel diagnostic assay for the rapid identification of invasive pulmonary mould infections. 4 CD154 is a T-cell activation marker transiently expressed on CD4 + cells upon stimulation of their T-cell receptor. Different studies showed that ex vivo stimulation of mononuclear cells followed by flow cytometric quantification of CD154-positive cells is a sensitive and convenient approach for the assessment of antigen-specific T-cell response. 5, 6, 7 Since treatment trials with Aspergillus-specific T-cells are being developed, monitoring of the frequency of circulating Aspergillus-specific T-cells in patients at risk, especially after T-cell transfer will receive special attention. 8 In invasive mould infections, the sensitivity and specificity of this assay for the occurrence of invasive fungal infections (IFI) was reported to exceed the results of currently available blood tests including galactomannan or polymerase chain reaction. 4 For integrating this approach in the diagnostic routine, however, further assessment is required to determine the reliability of the assay depending on the preanalytical sample handling. Sample shipment to specialized centers may cause preanalytic delays and may thus impact the reliability of the results provided by the assay. In this study, we therefore examined the impact of different preanalytical storage periods and conditions on the outcome of the quantification of CD154 + A. fumigatus-specific T cells. Donors whose frequency of A. fumigatus-specific T cells exceeded the mean value of the cohort were enrolled in a time course experiment. Blood was drawn every two hours and stored at room temperature (RT) or 4
Materials and methods
• C for up to 6 h prior to conducting the assay. Additionally, 1 × 10 7 PBMCs purified from the immediately processed blood were frozen in RPMI 1640 + 20% autologous serum + 8% DMSO. After freezing at −20 • C for 24-48 h or −80 • C for 6-8 days, stimulation and quantification of A. fumigatus-specific cells were performed as described above.
Results
An average frequency of 0.12% (range: 0%-0.43%) A. fumigatus-specific CD154 + /CD4 + T cells was found in immediately purified PBMC samples obtained from healthy donors. Using technical duplicates for each donor, the mean intra-assay difference for the frequency of A. fumigatusspecific T cells was 0.01% with a maximum of 0.07%. This is indicative for a reliable assay setup allowing a highly reproducible quantification of A. fumigatus-specific cells. Six donors with an A. fumigatus-specific T-cell frequency of ≥0.12% were enrolled in the second part of the study. Their mean A. fumigatus-specific T-cell frequency in freshly obtained and processed samples was 0.26%. Storing the blood samples at either RT or 4
• C for 2 h prior to the isolation of the PBMCs, this frequency declined to 0.15% (P = .13) and 0.16% (P = .04), respectively. After a 6-h preanalytic storage period at RT or 4
• C, an even lower mean frequency of A. fumigatus-specific T-cells was found (0.10%, P = .05 and 0.10%, P = .03, respectively; Fig. 1A) . Unspecific background signals needed to be considered. Therefore, the frequency of CD154 + /CD4 + cells in samples cultured with the CD28 costimulatory antibody, without the lysate, was also determined. In immediately processed samples the average background frequency was 0.03%. After 2-h sample storage at RT or 4
• C, this frequency increased to 0.08% and 0.05%. During the following 4 hours, a further rise of the background frequency was observed (0.10% and 0.08%; Fig. 1B ). The poor detection of A. fumigatus-specific T cells after preanalytic sample storage in combination with this increased unspecific background frequency of CD154 + /CD4 + cells resulted in a markedly declined overall sensitivity of the assay after 2 hours and a completely reduced sensitivity after 6 hours (Fig. 1C) . Similarly, the detection rates of CD154 + /CD4 + cells (Fig. 1D) and IFNγ + /CD3 + cells (Fig. 1E ) in EBV-stimulated PBMCs declined after 6-h sample storage at RT, suggesting an assay impairment by preanalytic delay, which is not antigen specific. Accordingly, cell viability and frequencies of CD14 + antigen presenting cells were reduced in samples stored for 6 h at either RT or 4
• C (Fig. 2B-C ).
PBMCs were isolated from the same donors and frozen promptly after the blood draw; however, these were stimulated and measured later. Subtracting the unspecific background, a mean frequency of 0.21% A. fumigatus-specific T cells was detected. These results were basically identical to the ones found in immediately processed cells from the same donor (Fig 2A) . Similarly, cell viability and frequency of CD14 + cells remained largely unchanged compared to freshly isolated cells (Fig. 2B-C) .
To further test the reliability of the quantification of A. fumigatus-specific T cells after freezing of PBMCs, the assay was comparatively performed using frozen and thawed PBMCs from 16 healthy donors (Fig. 2D) . Ten samples were stored at −20
• C for 24-48 h, and 6 were frozen at −80 • C for 6-8 days. In all cases, the difference of the frequencies of A. fumigatus-specific T cells in both samples was lower than the highest intra-assay deviation observed in technical replicates using freshly isolated cells (0.07%).
Discussion
In summary, A. fumigatus-specific T cells can be quantified in a highly reliable manner using freshly purified PBMC samples. The mean values and the range of A. fumigatusspecific T-cell frequencies were comparable to the observations in a previous study. 4 Our data, however, are indicative for a highly reduced sensitivity of the assay if the blood samples are not processed appropriately. As functional Tcell assays rely on the interaction of antigen presenting cells + (E) EBV-specific T-cells in 6 additional donors using freshly isolated PBMCs and blood samples stored at RT for 6 hours. Significance testing was performed using the paired two-sided Student's t-test. P > .1 ns, P < .1 , P < .05 * .
and T-helper cells, it is quite understandable that a dysbalance of the cell subsets, reduced viability, or functionality may impair the results. Several studies evaluating the performance of T-cell assays in infectious diseases highlighted that blood collection, sample storage, and blood shipment conditions are crucial for reliable test performances. 9, 10, 11 Particularly, the time between blood collection and sample processing appears to be the most critical parameter greatly affecting cell recovery and function. 9, 10, 11, 12 This observation is explained by increasing granulocyte contamination of the PBMC isolates due to granulocyte aggregation, reduced T-cell responsiveness, or biochemical alterations caused by an increasing fragility of erythrocytes and granulocytes. 10, 12, 13, 14 Given the relatively lengthy assay procedure for the quantification of A. fumigatus specific T cells and the circumstances of sample shipment, our observations highlight significant logistical challenges for using this assay in the diagnostic routine. Our results demonstrate that freezing of immediately isolated PBMCs at the patient's local center with subsequent storage and shipment is easily feasible and may contribute to overcome multiple challenges. This optimization will require widely harmonized protocols for sample collection, PBMC isolation, and shipment. Hence, further standardization of functional T-cell assays in infectious diseases is strongly recommended.
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